A Continuation Trial for Subjects With Lupus That Completed Protocol HGS1006-C1056 or HGS1006-C1057

Clinical trial NCT00712933 · COMPLETED

Trial details

NCT number: NCT00712933
Sponsor: Human Genome Sciences Inc., a GSK Company
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Systemic Lupus Erythematosus

Start date: 2008-05-30
Primary completion: 2016-12-09
Enrollment: 738

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.